Medical Condition News

RSS

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the enrollment and completed dosing of the first XLHED-affected neonate in a Phase 2 trial of EDI200, the company's novel, proprietary, recombinant protein.

9 Oct 2013

Alkermes completes patient enrollment in phase 3 study of aripiprazole lauroxil in schizophrenia patients

Alkermes plc (NASDAQ: ALKS) today announced completion of patient enrollment in the pivotal, multinational phase 3 study evaluating aripiprazole lauroxil in patients with schizophrenia.

9 Oct 2013

Quintiles and MDA partner to develop U.S. Neuromuscular Disease Registry

Quintiles and the Muscular Dystrophy Association (MDA) today announced a new partnership to develop and implement the U.S. Neuromuscular Disease Registry, a patient registry that will play an important role in determining effective treatments for people with muscular dystrophy and related muscle diseases.

9 Oct 2013

Moximed initiates pivotal trial of KineSpring System implantation in knee osteoarthritis patients

Moximed, Inc. announced today that the KineSpring® System, an implantable medical spring for knee osteoarthritis that works by unloading the weight on the diseased joint, has been successfully implanted in the first patients enrolled in the UK arm of its multi-centre GOAL study.

9 Oct 2013

ReAttach therapy can be effective treatment for people with autism

"ReAttach" is a new intervention, based on "attachment". Practical research has pointed out that the "ReAttach therapy" can be of great importance for people with autism. This is concluded from the continuous practical research of Paula Bartholomeus into the advantages that can be reached for people with Asperger's syndrome, PDD-NOS, autism spectrum disorder, or with a mental disability and autism, using the ReAttach therapy.

9 Oct 2013

Alnylam advances Development Candidate for ALN-AS1 for treatment of hepatic porphyrias

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it is advancing its Development Candidate for ALN-AS1, an RNAi therapeutic targeting aminolevulinate synthase-1 (ALAS-1) for the treatment of hepatic porphyrias including acute intermittent porphyria (AIP).

9 Oct 2013

Acorda Therapeutics initiates second clinical trial of Glial Growth Factor 2 in heart failure patients

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the first patient has been enrolled in the second clinical trial of Glial Growth Factor 2 (GGF2). This Phase 1b single-infusion trial in people with heart failure will assess tolerability of three dose levels of GGF2, and also includes several explorative measures of efficacy.

9 Oct 2013

MRFBC launches clinical trial to assess impact of bevacizumab and vemurafenib in melanoma patients

The Melanoma Research Foundation Breakthrough Consortium has launched a new clinical trial to assess the impact of concomitant administration of bevacizumab (Avastin) with vemurafenib (Zelboraf) in patients with BRAFV600 mutation positive metastatic melanoma.

8 Oct 2013

LSTM professor wins Universal Biotech Innovation Prize 2013 for Hexagard

Professor Richard Pleass has won the Prix de l’Innovation 2013, also known as the Universal Biotech Innovation Prize 2013.

8 Oct 2013

Brain & Behavior Research Foundation to hold research symposium on mental health

The Brain & Behavior Research Foundation, an organization dedicated to improving the lives of those with mental illness through the transformative power of neuroscience and psychiatric research, will hold its 25th Annual Mental Health Research Symposium on Friday, October 25th from 9:00 am to 4:30 p.m. at the Kaufman Music Center, located at 129 W. 67th St. in New York City.

8 Oct 2013

New stand-alone intervertebral body fusion device gets FDA clearance

Surgeons treating patients with degenerative disc disease may now use a new stand-alone intervertebral body fusion device recently cleared by the Food and Drug Administration. Manufactured by Binder Biomedical Inc., the device presents a complete anterior lumbar fixation system with a simple, one-step locking mechanism.

8 Oct 2013

Publication provides update on the origins and causes of anxiety disorders

Anxiety disorders are not uncommon and are often 'comorbid' with other forms of mental disorders. This publication provides an update on the origins and the causes of anxiety disorders and their related symptoms.

8 Oct 2013

Diabetic retinopathy incidence in upward trend

Retinal damage is one of the most common complications of diabetes, affecting about 90 percent of type 1 diabetics and 75 percent of type 2 diabetics. According to the World Health Organization (WHO), diabetic retinopathy is the leading cause of blindness in adults of working age, and its incidence is showing an upward trend.

8 Oct 2013

Study of fruit flies could help better understand food choice in obese people

Think of the smell of freshly baking bread. There is something in that smell, without any other cues - visual or tactile - that steers you toward the bakery. On the flip side, there may be a smell, for instance that of fresh fish, that may not appeal to you. If you haven't eaten a morsel of food in three days, of course, a fishy odor might seem a good deal more attractive.

8 Oct 2013

Only small proportion of adults receive formal diagnosis, treatment for ADHD

Up to two-thirds of children with attention deficit/hyperactivity disorder find their disorder persists into adulthood yet only a small proportion of adults ever receive a formal diagnosis and treatment, research suggests.

8 Oct 2013

Chiropractic doctors encourage people to embrace healthy lifestyle choices

With the obesity rate in the country increasing, doctors of chiropractic are encouraging people to embrace healthy lifestyle choices. Incorporating proper nutrition, a disciplined exercise plan and chiropractic care makes it easier to accomplish wellness goals. Small changes like decreasing food portion size or increasing your activity each day, can produce positive changes in overall health.

8 Oct 2013

CARUNDA24: A non-invasive continuous blood pressure measurement system

Freienbach, Switzerland: About 1 in 4 people in Switzerland suffer from high blood pressure; worldwide more than 1 billion people are affected increasing the risk of heart attack, cerebral haemorrhage or a stroke. Unfortunately, most affected people don't measure their blood pressure regularly as the measurement method is too complicated and uncomfortable to be part of a daily routine.

8 Oct 2013

Study: Women with eating disorders are less likely to have children

Women with eating disorders are less likely to have children than others in the same age group, indicates a study conducted at the University of Helsinki, Finland. The likelihood for miscarriage was more than triple for binge-eating disorder (BED) sufferers and the likelihood of abortion more than double for bulimics than others in the same age group.

8 Oct 2013

Personalised therapy can reduce risk of cardiac disease among diabetes patients

600,000 to 800,000 Austrians suffer from diabetes mellitus. Thanks to the biomarker known as NT-proBNP (a hormone specific to the heart), the sub-group of people who are at increased risk of cardiovascular disease can be determined even though their hearts appear to be healthy.

8 Oct 2013

Study casts light on how health care providers respond to physical violence among female veterans

A new study, published in Springer's Journal of Family Violence, casts light on how health care providers respond to the emotional, sexual and physical violence that female veterans sometimes experience at the hands of their intimate partners.

8 Oct 2013

Medical Condition News

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Alkermes completes patient enrollment in phase 3 study of aripiprazole lauroxil in schizophrenia patients

Quintiles and MDA partner to develop U.S. Neuromuscular Disease Registry

Moximed initiates pivotal trial of KineSpring System implantation in knee osteoarthritis patients

ReAttach therapy can be effective treatment for people with autism

Alnylam advances Development Candidate for ALN-AS1 for treatment of hepatic porphyrias

Acorda Therapeutics initiates second clinical trial of Glial Growth Factor 2 in heart failure patients

MRFBC launches clinical trial to assess impact of bevacizumab and vemurafenib in melanoma patients

LSTM professor wins Universal Biotech Innovation Prize 2013 for Hexagard

Brain & Behavior Research Foundation to hold research symposium on mental health

New stand-alone intervertebral body fusion device gets FDA clearance

Publication provides update on the origins and causes of anxiety disorders

Diabetic retinopathy incidence in upward trend

Study of fruit flies could help better understand food choice in obese people

Only small proportion of adults receive formal diagnosis, treatment for ADHD

Chiropractic doctors encourage people to embrace healthy lifestyle choices

CARUNDA24: A non-invasive continuous blood pressure measurement system

Study: Women with eating disorders are less likely to have children

Personalised therapy can reduce risk of cardiac disease among diabetes patients

Study casts light on how health care providers respond to physical violence among female veterans

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News